Showing results (501-510 of 572) with videos related to

Sort By:
Pageof 58
Clinical Kidney Journal|August 21, 2024
Long-term effect of increasing water intake on repeated self-assessed health-related quality of life (HRQoL) in autosomal dominant polycystic kidney diseaseGopala Rangan, Margaret Allman-Farinelli, Neil Boudville, et al.
Circulation|February 8, 2021
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE TrialNan Ye, Meg J Jardine, Megumi Oshima, et al.
Kidney International Reports|February 20, 2026
Impact of CKD on Life Participation in Latin AmericaAndrea Matus Gonzalez, Anastasia Hughes, Soledad Molina, et al.
JAMA|August 2, 2017
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical TrialJicheng Lv, Hong Zhang, Muh Geot Wong, et al.
American Journal of Nephrology|November 3, 2021
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline CharacteristicsMuh Geot Wong, Jicheng Lv, Michelle A Hladunewich, et al.
Kidney International Reports|June 2, 2018
Risk Factors for Prognosis in Patients With Severely Decreased GFRMarie Evans, Morgan E Grams, Yingying Sang, et al.
Kidney International Supplements|May 13, 2021
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Latin AmericaMarina Wainstein, Aminu K Bello, Vivekanand Jha, et al.
Kidney International Reports|March 18, 2021
Roxadustat for CKD-related Anemia in Non-dialysis PatientsDaniel W Coyne, Simon D Roger, Sug Kyun Shin, et al.
Kidney360|December 8, 2025
Longitudinal Assessment of Health-Related Quality of Life in Adult with CKDOwen Ng, Armando Teixeira-Pinto, Anh Kieu, et al.
Circulation|February 16, 2006
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) ProgramEileen O'Meara, Tim Clayton, Margaret B McEntegart, et al.
Pageof 58